A citation-based method for searching scientific literature

Carina Storrs. Health Aff (Millwood) 2018
Times Cited: 6







List of co-cited articles
42 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


The dawn of consumer-directed testing.
Erica Ramos, Scott M Weissman. Am J Med Genet C Semin Med Genet 2018
27
50


Intraepithelial T cells and tumor proliferation: impact on the benefit from surgical cytoreduction in advanced serous ovarian cancer.
Sarah F Adams, Douglas A Levine, Mark G Cadungog, Rachel Hammond, Andrea Facciabene, Narciso Olvera, Stephen C Rubin, Jeff Boyd, Phyllis A Gimotty, George Coukos. Cancer 2009
87
33


Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial.
M William Audeh, James Carmichael, Richard T Penson, Michael Friedlander, Bethan Powell, Katherine M Bell-McGuinn, Clare Scott, Jeffrey N Weitzel, Ana Oaknin, Niklas Loman,[...]. Lancet 2010
941
33

Identifying driver mutations from sequencing data of heterogeneous tumors in the era of personalized genome sequencing.
Jing Zhang, Jie Liu, Jianbo Sun, Chen Chen, Gregory Foltz, Biaoyang Lin. Brief Bioinform 2014
23
33

Defining precision: The precision medicine initiative trials NCI-MPACT and NCI-MATCH.
Geraldine O'Sullivan Coyne, Naoko Takebe, Alice P Chen. Curr Probl Cancer 2017
54
33

Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer.
Lin Zhang, Jose R Conejo-Garcia, Dionyssios Katsaros, Phyllis A Gimotty, Marco Massobrio, Giorgia Regnani, Antonis Makrigiannakis, Heidi Gray, Katia Schlienger, Michael N Liebman,[...]. N Engl J Med 2003
33

Distinct evolutionary trajectories of primary high-grade serous ovarian cancers revealed through spatial mutational profiling.
Ali Bashashati, Gavin Ha, Alicia Tone, Jiarui Ding, Leah M Prentice, Andrew Roth, Jamie Rosner, Karey Shumansky, Steve Kalloger, Janine Senz,[...]. J Pathol 2013
262
33


The cancer genome.
Michael R Stratton, Peter J Campbell, P Andrew Futreal. Nature 2009
33


OCEANS: a randomized, double-blind, placebo-controlled phase III trial of chemotherapy with or without bevacizumab in patients with platinum-sensitive recurrent epithelial ovarian, primary peritoneal, or fallopian tube cancer.
Carol Aghajanian, Stephanie V Blank, Barbara A Goff, Patricia L Judson, Michael G Teneriello, Amreen Husain, Mika A Sovak, Jing Yi, Lawrence R Nycum. J Clin Oncol 2012
781
33


Personalized cancer vaccine effectively mobilizes antitumor T cell immunity in ovarian cancer.
Janos L Tanyi, Sara Bobisse, Eran Ophir, Sandra Tuyaerts, Annalisa Roberti, Raphael Genolet, Petra Baumgartner, Brian J Stevenson, Christian Iseli, Denarda Dangaj,[...]. Sci Transl Med 2018
171
33

Bevacizumab and paclitaxel-carboplatin chemotherapy and secondary cytoreduction in recurrent, platinum-sensitive ovarian cancer (NRG Oncology/Gynecologic Oncology Group study GOG-0213): a multicentre, open-label, randomised, phase 3 trial.
Robert L Coleman, Mark F Brady, Thomas J Herzog, Paul Sabbatini, Deborah K Armstrong, Joan L Walker, Byoung-Gie Kim, Keiichi Fujiwara, Krishnansu S Tewari, David M O'Malley,[...]. Lancet Oncol 2017
243
33


Impact of deleterious passenger mutations on cancer progression.
Christopher D McFarland, Kirill S Korolev, Gregory V Kryukov, Shamil R Sunyaev, Leonid A Mirny. Proc Natl Acad Sci U S A 2013
177
33

Bevacizumab combined with chemotherapy for platinum-resistant recurrent ovarian cancer: The AURELIA open-label randomized phase III trial.
Eric Pujade-Lauraine, Felix Hilpert, Béatrice Weber, Alexander Reuss, Andres Poveda, Gunnar Kristensen, Roberto Sorio, Ignace Vergote, Petronella Witteveen, Aristotelis Bamias,[...]. J Clin Oncol 2014
766
33

Vaccination with an NY-ESO-1 peptide of HLA class I/II specificities induces integrated humoral and T cell responses in ovarian cancer.
Kunle Odunsi, Feng Qian, Junko Matsuzaki, Paulette Mhawech-Fauceglia, Christopher Andrews, Eric W Hoffman, Linda Pan, Gerd Ritter, Jeannine Villella, Bridget Thomas,[...]. Proc Natl Acad Sci U S A 2007
185
33

PTEN/PTENP1: 'Regulating the regulator of RTK-dependent PI3K/Akt signalling', new targets for cancer therapy.
Nahal Haddadi, Yiguang Lin, Glena Travis, Ann M Simpson, Najah T Nassif, Eileen M McGowan. Mol Cancer 2018
82
33

Immunotherapy in ovarian cancer.
Gina M Mantia-Smaldone, Bradley Corr, Christina S Chu. Hum Vaccin Immunother 2012
30
33

Adjuvants for enhancing the immunogenicity of whole tumor cell vaccines.
Cheryl Lai-Lai Chiang, Lana E Kandalaft, George Coukos. Int Rev Immunol 2011
69
33

Genetic tests obtainable through pharmacies: the good, the bad, and the ugly.
George P Patrinos, Darrol J Baker, Fahd Al-Mulla, Vasilis Vasiliou, David N Cooper. Hum Genomics 2013
24
33

The PI3K/AKT/mTOR pathway as a therapeutic target in ovarian cancer.
Seiji Mabuchi, Hiromasa Kuroda, Ryoko Takahashi, Tomoyuki Sasano. Gynecol Oncol 2015
238
33

New biologic agents for the treatment of gynecologic cancers.
Neil Horowitz, Ursula A Matulonis. Hematol Oncol Clin North Am 2012
3
66

Integrated genomic characterization of endometrial carcinoma.
Cyriac Kandoth, Nikolaus Schultz, Andrew D Cherniack, Rehan Akbani, Yuexin Liu, Hui Shen, A Gordon Robertson, Itai Pashtan, Ronglai Shen, Christopher C Benz,[...]. Nature 2013
33

Genomic insights in gynecologic cancer.
Erika Roddy, Jocelyn Chapman. Curr Probl Cancer 2017
5
40

Ovarian Cancers: Genetic Abnormalities, Tumor Heterogeneity and Progression, Clonal Evolution and Cancer Stem Cells.
Ugo Testa, Eleonora Petrucci, Luca Pasquini, Germana Castelli, Elvira Pelosi. Medicines (Basel) 2018
68
33


The NCI-MATCH trial and precision medicine in gynecologic cancers.
Lisa Barroilhet, Ursula Matulonis. Gynecol Oncol 2018
24
33

Immunotherapy opportunities in ovarian cancer.
Christina S Chu, Sarah H Kim, Carl H June, George Coukos. Expert Rev Anticancer Ther 2008
47
33

Improved survival with bevacizumab in advanced cervical cancer.
Krishnansu S Tewari, Michael W Sill, Harry J Long, Richard T Penson, Helen Huang, Lois M Ramondetta, Lisa M Landrum, Ana Oaknin, Thomas J Reid, Mario M Leitao,[...]. N Engl J Med 2014
696
33

Adoption of pharmacogenomic testing by US physicians: results of a nationwide survey.
E J Stanek, C L Sanders, K A Johansen Taber, M Khalid, A Patel, R R Verbrugge, B C Agatep, R E Aubert, R S Epstein, F W Frueh. Clin Pharmacol Ther 2012
268
33

Direct-to-Consumer Testing 2.0: Emerging Models of Direct-to-Consumer Genetic Testing.
Megan A Allyse, David H Robinson, Matthew J Ferber, Richard R Sharp. Mayo Clin Proc 2018
55
33

Physician-Reported Benefits and Barriers to Clinical Implementation of Genomic Medicine: A Multi-Site IGNITE-Network Survey.
Aniwaa Owusu Obeng, Kezhen Fei, Kenneth D Levy, Amanda R Elsey, Toni I Pollin, Andrea H Ramirez, Kristin W Weitzel, Carol R Horowitz. J Pers Med 2018
57
33


Health-care referrals from direct-to-consumer genetic testing.
Monica A Giovanni, Matthew R Fickie, Lisa S Lehmann, Robert C Green, Lisa M Meckley, David Veenstra, Michael F Murray. Genet Test Mol Biomarkers 2010
38
33

Primary care physicians' knowledge of and experience with pharmacogenetic testing.
S B Haga, W Burke, G S Ginsburg, R Mills, R Agans. Clin Genet 2012
160
33

Consumer Perceptions of Interactions With Primary Care Providers After Direct-to-Consumer Personal Genomic Testing.
Cathelijne H van der Wouden, Deanna Alexis Carere, Anke H Maitland-van der Zee, Mack T Ruffin, J Scott Roberts, Robert C Green. Ann Intern Med 2016
66
33

False-positive results released by direct-to-consumer genetic tests highlight the importance of clinical confirmation testing for appropriate patient care.
Stephany Tandy-Connor, Jenna Guiltinan, Kate Krempely, Holly LaDuca, Patrick Reineke, Stephanie Gutierrez, Phillip Gray, Brigette Tippin Davis. Genet Med 2018
113
33


Big Data: Astronomical or Genomical?
Zachary D Stephens, Skylar Y Lee, Faraz Faghri, Roy H Campbell, Chengxiang Zhai, Miles J Efron, Ravishankar Iyer, Michael C Schatz, Saurabh Sinha, Gene E Robinson. PLoS Biol 2015
361
16


Intersection of DNA privacy and whole-genome sequencing.
Changjin Hong, Jason Wang, Chao Xing, Tae Hyun Hwang, Jason Y Park. Clin Chem 2015
1
100

Genetics for the Identification of Lipid Targets Beyond PCSK9.
Linda R Wang, Robert A Hegele. Can J Cardiol 2017
7
16

The International Cancer Genome Consortium's evolving data-protection policies.
Djims Milius, Edward S Dove, Donald Chalmers, Stephanie O M Dyke, Kazuto Kato, Pilar Nicolás, B F Francis Ouellette, Brad Ozenberger, Laura L Rodriguez, Nikolajs Zeps,[...]. Nat Biotechnol 2014
13
16

Identifying personal genomes by surname inference.
Melissa Gymrek, Amy L McGuire, David Golan, Eran Halperin, Yaniv Erlich. Science 2013
469
16

Patient awareness and approval for an opt-out genomic biorepository.
Kyle B Brothers, Mathew J Westbrook, M Frances Wright, John A Myers, Daniel R Morrison, Jennifer L Madison, Jill M Pulley, Ellen Wright Clayton. Per Med 2013
10
16



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.